1. Home
  2. VBNK vs EYPT Comparison

VBNK vs EYPT Comparison

Compare VBNK & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBNK
  • EYPT
  • Stock Information
  • Founded
  • VBNK 1980
  • EYPT 1987
  • Country
  • VBNK Canada
  • EYPT United States
  • Employees
  • VBNK N/A
  • EYPT N/A
  • Industry
  • VBNK Commercial Banks
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • VBNK Finance
  • EYPT Industrials
  • Exchange
  • VBNK Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • VBNK 441.5M
  • EYPT 489.4M
  • IPO Year
  • VBNK 2021
  • EYPT 2005
  • Fundamental
  • Price
  • VBNK $12.69
  • EYPT $6.15
  • Analyst Decision
  • VBNK Strong Buy
  • EYPT Strong Buy
  • Analyst Count
  • VBNK 3
  • EYPT 8
  • Target Price
  • VBNK $19.00
  • EYPT $25.71
  • AVG Volume (30 Days)
  • VBNK 87.6K
  • EYPT 886.1K
  • Earning Date
  • VBNK 03-05-2025
  • EYPT 03-06-2025
  • Dividend Yield
  • VBNK 0.57%
  • EYPT N/A
  • EPS Growth
  • VBNK N/A
  • EYPT N/A
  • EPS
  • VBNK 1.07
  • EYPT N/A
  • Revenue
  • VBNK $80,302,117.00
  • EYPT $45,713,000.00
  • Revenue This Year
  • VBNK N/A
  • EYPT N/A
  • Revenue Next Year
  • VBNK $40.97
  • EYPT N/A
  • P/E Ratio
  • VBNK $14.89
  • EYPT N/A
  • Revenue Growth
  • VBNK 3.59
  • EYPT 7.50
  • 52 Week Low
  • VBNK $9.48
  • EYPT $5.90
  • 52 Week High
  • VBNK $18.38
  • EYPT $29.31
  • Technical
  • Relative Strength Index (RSI)
  • VBNK 31.84
  • EYPT 36.22
  • Support Level
  • VBNK $13.36
  • EYPT $5.90
  • Resistance Level
  • VBNK $13.86
  • EYPT $6.67
  • Average True Range (ATR)
  • VBNK 0.44
  • EYPT 0.71
  • MACD
  • VBNK -0.07
  • EYPT -0.04
  • Stochastic Oscillator
  • VBNK 2.21
  • EYPT 8.99

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: